1315 Capital is a private investment firm focused on providing expansion and growth capital to commercial-stage medical technology, healthcare service and specialty therapeutic companies. Founded in 2014 and headquartered in Philadelphia, they target $10-30 million investments with the potential to scale to $100 million revenue with the option for acquisition or public offering.
1315 Capital prefers to work in what they call an operating partner model of CEO and COO Executive, where 1315 works to leverage their operating teams experience to help build investment companies.
Their investments include Aktana, BioCoat, Inc., Centurion, CHC Solutions, Inc., Colorescience, Encore Dermatology, Genoptix, Greenbrook NeuroHealth Centers, Innovative Health, JDS Therapeutics, Onkos Surgical, Restorative Therapies and Solsys Medical.
Associated investment funds
Documentaries, videos and podcasts